We did not record assessments of inflammation (serologic such as leukocytosis, ESR, and CRP or pathologic findings), which could have influenced clinicians’ decision-making related to antimicrobial de-escalation or discontinuation and the shortening of antimicrobial regimens. This evidence concerns the gene CRP and Increased total leukocyte count.